In yesterday’s Wall Street session, Bristol-Myers Squibb Company (NYSE:BMY) shares traded at $62.85, up 1.96% from the previous session.
26 analysts cover Bristol-Myers Squibb Company (NYSE:BMY), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $90.00 and a low of $56.00, we find $74.50. Given the previous closing price of $61.64, this indicates a potential upside of 20.86 percent. BMY stock price is now 0.24% away from the 50-day moving average and -8.82% away from the 200-day moving average. The market capitalization of the company currently stands at $129.61B.
The stock has received a hold rating from 11 analysts and a buy rating from 12. Brokers who have rated the stock have averaged $73.27 as their price target over the next twelve months.
With the price target of $56, HSBC Securities recently initiated with Reduce rating for Bristol-Myers Squibb Company (NYSE: BMY).
In other news, Powell Ann, EVP, Chief Human Resources sold 17,986 shares of the company’s stock on Aug 24. The stock was sold for $1,101,642 at an average price of $61.25. Upon completion of the transaction, the EVP, Chief Human Resources now directly owns 27,868 shares in the company, valued at $1.75 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 03, EVP, Chief Research Officer Plenge Robert M sold 732 shares of the business’s stock. A total of $44,754 was realized by selling the stock at an average price of $61.14. This leaves the insider owning 6,584 shares of the company worth $0.41 million. Insiders disposed of 963,343 shares of company stock worth roughly $60.55 million over the past 1 year. A total of 0.07% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in BMY stock. A new stake in Bristol-Myers Squibb Company shares was purchased by MARSHALL WACE, LLP during the first quarter worth $121,585,000. LAURION CAPITAL MANAGEMENT LP invested $53,003,000 in shares of BMY during the first quarter. In the first quarter, CAMBIAR INVESTORS LLC acquired a new stake in Bristol-Myers Squibb Company valued at approximately $40,177,000. PORTSIDE WEALTH GROUP, LLC acquired a new stake in BMY for approximately $32,983,000. UNISUPER MANAGEMENT PTY LTD purchased a new stake in BMY valued at around $26,915,000 in the second quarter. In total, there are 3,229 active investors with 79.40% ownership of the company’s stock.
On Tuesday morning Bristol-Myers Squibb Company (NYSE: BMY) stock kicked off with the opening price of $61.98. During the past 12 months, Bristol-Myers Squibb Company has had a low of $59.71 and a high of $81.43. As of last week, the company has a debt-to-equity ratio of 1.18, a current ratio of 1.40, and a quick ratio of 1.30. According to the stock market information, the enterprise value for the company is $159.23B, which is based on a 16.73 price-to-earnings ratio, a 12.16 price-to-earnings-growth ratio, and a beta of 0.41. The fifty day moving average price for BMY is $62.63 and a two-hundred day moving average price translates $68.85 for the stock.
The latest earnings results from Bristol-Myers Squibb Company (NYSE: BMY) was released for Jun, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $1.75, missing analysts’ expectations of $1.98 by -0.23. This compares to $0.67 EPS in the same period last year. The net profit margin was 17.60% and return on equity was 25.00% for BMY. The company reported revenue of $11.23 billion for the quarter, compared to $11.89 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -5.56 percent. For the current quarter, analysts expect BMY to generate $11.05B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 08/01/2023. Investors who held shares on 07/07/2023 were paid a $0.57 dividend. On an annualized basis, this represents a $2.28 dividend and a 3.63% percent yield. There was an ex-dividend date of 07/06/2023 for this dividend. In terms of dividend payout ratio, BMY is presently at 58.70%.
